
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patien... ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.86 | 12.4874118832 | 14.895 | 18.25 | 13.5001 | 3893266 | 17.10120859 | CS |
4 | 0.305 | 1.85410334347 | 16.45 | 18.25 | 13.5001 | 2642771 | 16.36179565 | CS |
12 | -2.025 | -10.7827476038 | 18.78 | 19.25 | 13.5001 | 2468294 | 16.81665653 | CS |
26 | -0.495 | -2.86956521739 | 17.25 | 23.64 | 13.5001 | 3745708 | 18.41765839 | CS |
52 | 10.435 | 165.110759494 | 6.32 | 23.64 | 5.88 | 3453410 | 15.12511204 | CS |
156 | 14.975 | 841.292134831 | 1.78 | 23.64 | 1.43 | 2850638 | 8.03695933 | CS |
260 | 14.275 | 575.60483871 | 2.48 | 23.64 | 1.01 | 3215758 | 5.2733525 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.